Lobo, D S S
Aleksandrova, L
Knight, J
Casey, D M
el-Guebaly, N
Nobrega, J N
Kennedy, J L
Article History
Received: 16 July 2013
Revised: 30 July 2014
Accepted: 4 August 2014
First Online: 30 September 2014
Competing interests
: The authors declare that Dr Kennedy has received honorarium from Roche Pharma, Lilly, and Novartis in the last three years.